Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

Kunihiro Matsushita, Marije van der Velde, Brad C. Astor, Mark Woodward, Andrew S. Levey, Paul E. de Jong, Josef Coresh, Ron T. Gansevoort, Meguid El-Nahas, Kai Uwe Eckardt, Bertram L. Kasiske, Marcello Tonelli, Brenda Hemmelgarn, Yaping Wang, Robert C. Atkins, Kevan R. Polkinghorne, Steven J. Chadban, Anoop Shankar, Ronald Klein, Barbara E.K. KleinHaiyan Wang, Fang Wang, Luxia Zhang, Lisheng Liu, Michael Shlipak, Mark J. Sarnak, Ronit Katz, Linda P. Fried, Tazeen Jafar, Muhammad Islam, Juanita Hatcher, Neil Poulter, Nish Chaturvedi, Dietrich Rothenbacher, Hermann Brenner, Elke Raum, Wolfgang Koenig, Caroline S. Fox, Shih Jen Hwang, James B. Meigs, Massimo Cirillo, Stein Hallan, Stian Lydersen, Jostein Holmen, Michael Shlipak, Mark J. Sarnak, Ronit Katz, Linda P. Fried, Paul Roderick, Dorothea Nitsch, Astrid Fletcher, Christopher Bulpitt, Takayoshi Ohkubo, Hirohito Metoki, Masaaki Nakayama, Masahiro Kikuya, Yutaka Imai, Simerjot Kaur Jassal, Elizabeth Barrett-Connor, Jaclyn Bergstrom, David G. Warnock, Paul Muntner, Suzanne Judd, William M. McClellan, Mary Cushman, George Howard, Leslie A. McClure, Sun Ha Jee, Heejin Kimm, Ji Eun Yun, Chi Pang Wen, Sung Feng Wen, Chwen Keng Tsao, Min Kuang Tsai, Johan Ärnlöv, Priscilla Auguste, Kasper Veldhuis, Laura Camarata, Beverly Thomas, Tom Manley

Résultat de rechercheexamen par les pairs

3333 Citations (Scopus)

Résumé

Background: Substantial controversy surrounds the use of estimated glomerular filtration rate (eGFR) and albuminuria to define chronic kidney disease and assign its stages. We undertook a meta-analysis to assess the independent and combined associations of eGFR and albuminuria with mortality. Methods: In this collaborative meta-analysis of general population cohorts, we pooled standardised data for all-cause and cardiovascular mortality from studies containing at least 1000 participants and baseline information about eGFR and urine albumin concentrations. Cox proportional hazards models were used to estimate hazard ratios (HRs) for all-cause and cardiovascular mortality associated with eGFR and albuminuria, adjusted for potential confounders. Findings: The analysis included 105 872 participants (730 577 person-years) from 14 studies with urine albumin-to-creatinine ratio (ACR) measurements and 1 128 310 participants (4 732 110 person-years) from seven studies with urine protein dipstick measurements. In studies with ACR measurements, risk of mortality was unrelated to eGFR between 75 mL/min/1·73 m2 and 105 mL/min/1·73 m2 and increased at lower eGFRs. Compared with eGFR 95 mL/min/1·73 m2, adjusted HRs for all-cause mortality were 1·18 (95% CI 1·05-1·32) for eGFR 60 mL/min/1·73 m2, 1·57 (1·39-1·78) for 45 mL/min/1·73 m2, and 3·14 (2·39-4·13) for 15 mL/min/1·73 m2. ACR was associated with risk of mortality linearly on the log-log scale without threshold effects. Compared with ACR 0·6 mg/mmol, adjusted HRs for all-cause mortality were 1·20 (1·15-1·26) for ACR 1·1 mg/mmol, 1·63 (1·50-1·77) for 3·4 mg/mmol, and 2·22 (1·97-2·51) for 33·9 mg/mmol. eGFR and ACR were multiplicatively associated with risk of mortality without evidence of interaction. Similar findings were recorded for cardiovascular mortality and in studies with dipstick measurements. Interpretation: eGFR less than 60 mL/min/1·73 m2 and ACR 1·1 mg/mmol (10 mg/g) or more are independent predictors of mortality risk in the general population. This study provides quantitative data for use of both kidney measures for risk assessment and definition and staging of chronic kidney disease. Funding: Kidney Disease: Improving Global Outcomes (KDIGO), US National Kidney Foundation, and Dutch Kidney Foundation.

Langue d'origineEnglish
Pages (de-à)2073-2081
Nombre de pages9
JournalThe Lancet
Volume375
Numéro de publication9731
DOI
Statut de publicationPublished - 2010

Financement

The Chronic Kidney Disease Prognosis Consortium is supported by KDIGO and the US National Kidney Foundation. The meta-analyses undertaken jointly at Johns Hopkins School of Public Health, Baltimore, MD, USA, and University Medical Center Groningen, Groningen, Netherlands, were supported by the US National Kidney Foundation and the Dutch Kidney Foundation, respectively. KDIGO hosted the 2009 meeting of collaborators.

Bailleurs de fondsNuméro du bailleur de fonds
KDIGO
US National Kidney Foundation
National Institute on AgingR01AG028507
Johns Hopkins Bloomberg School of Public Health
National Kidney Foundation
Nierstichting
Universitair Medisch Centrum Groningen

    ASJC Scopus Subject Areas

    • General Medicine

    Empreinte numérique

    Plonger dans les sujets de recherche 'Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis'. Ensemble, ils forment une empreinte numérique unique.

    Citer